Prophylaxis
Prophylaxis - most related articles:
-
Complete response letter for Cinryze for hereditary angioedema - 3.1
-
Anticoagulant Dabigatran linked to heart attack or MI - 2.9
-
MRSA admission screening may not reduce staph infection rates - 2.3
-
ViroPharma's Maribavir failed in bone marrow transplant patients - 2.2
-
8 human cases of H5N1 avian influenza in Peshawar, Pakistan - 2.1
Prophylaxis articles
Marked reduction of HIV among circumcised adult menResearchers presenting late breaking research on the final day of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have focussed on new studies in the field of circumcision, pre-exposure prophylaxis (PrEP) and antiretroviral treatment. The IAS 2011 conference has been attended by over 5000 researchers, clinicians and community leaders since Sunday in Rome.
New GM-SCF therapy to defeating flu shows promiseNew research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus.
Gene biomarker to identify smokers for lung cancer riskResearchers from Boston University School of Medicine (BUSM) in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer.
4 new H1N1 cases reported from Delhi, IndiaHealth screening of passengers coming from affected countries is continuing in 21 International airports in India. 40815 passengers have been screened on 16.6.2009.
60 year old woman found positive for H1N1, DelhiThe 60 year old mother of the positive case [reported at Delhi on 7.6.2009] complained of mild symptoms and also tested positive. She got the infection from her son. They are on oseltamivir. All their contacts have been put on chemoprophylaxis.
Complete response letter for Cinryze for hereditary angioedemaViroPharma Incorporated (Nasdaq: VPHM) announced that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) related to its supplemental Biologics License Application (sBLA) for Cinryze(TM) (C1 esterase inhibitor [human]) as a treatment for acute attacks of hereditary angioedema (HAE).
ViroPharma's Maribavir failed in bone marrow transplant patientsViroPharma Incorporated (Nasdaq: VPHM) announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint.
AIDS drugs may prevent vaginal transmission of HIVPrescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, researchers at UT Southwestern Medical Center have found.
8 Prophylaxis articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.